Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2014; 03(03): 189
DOI: 10.4103/2278-330X.136821
Letters to Editor

Expected efficacy of HPV vaccine in prevention of cervix cancer in Thailand

Beuy Joob
Sanitation 1 Medical Academic Center, Bangkok, Thailand
,
Viroj Wiwanitkit
Visiting Professor, Hainan Medical University, China,
Visiting Professor, Faculty of Medicine, University of Nis, Serbia
Adjunct Professor, Joseph Ayobabalola University, Nigeria
Professor, Senior Expert, Public Health Curriculum Surin Rajabhat University, Surin, Thailand
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
31 December 2020

© 2014. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Altinbas SK, Tapisiz OL. Human papillomavirus, vaccines, and protection from cervical cancer. Saudi Med J 2012;33:1270-7.
  • 2 Tomljenovic L, Spinosa JP, Shaw CA. Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe? Curr Pharm Des 2013;19:1466-87.
  • 3 Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: A randomised, double-blind trial. Lancet 2009;373:1949-57.
  • 4 Songthap A, Pitisuttithum P, Kaewkungwal J, Fungladda W, Bussaratid V. Knowledge, attitudes, and acceptability of a human papilloma virus vaccine among students, parents and teachers in Thailand. Southeast Asian J Trop Med Public Health 2012;43:340-53.
  • 5 Termrungruanglert W, Havanond P, Khemapech N, Lertmaharit S, Pongpanich S, Khorprasert C, et al. Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries. Value Health 2012;15:S29-34.
  • 6 Chinchai T, Chansaenroj J, Swangvaree S, Junyangdikul P, Poovorawan Y. Prevalence of human papillomavirus genotypes in cervical cancer. Int J Gynecol Cancer 2012;22:1063-8.
  • 7 Henderson L, Clements A, Damery S, Wilkinson C, Austoker J, Wilson S, HPV Core Messages Writing Group. A false sense of security′? Understanding the role of the HPV vaccine on future cervical screening behaviour: A qualitative study of UK parents and girls of vaccination age. J Med Screen 2011;18:41-5.